Cystinosis: The evolution of a treatable disease

Pediatric Nephrology

Volumn 28, Issue 1, 2013, Pages 51-59

  Nesterova, Galina ^a   Gahl, William A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Complications; Cysteamine; Cystinosis; Fanconi; Nephropathic

Indexed keywords

BICARBONATE; CARNITINE; CITRATE SODIUM; CYSTINE; CYSTINOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; MEMBRANE PROTEIN; MERCAPTAMINE; PHOSPHATE; THIAZIDE DIURETIC AGENT; THYROXINE; UNCLASSIFIED DRUG; VITAMIN D;

AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CYSTINOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FANCONI RENOTUBULAR SYNDROME; FATALITY; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; METABOLIC ACIDOSIS; MYOPATHY; NAUSEA; NEPHROLOGIST; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RARE DISEASE; RENAL OSTEODYSTROPHY; RETINOPATHY; REVIEW; TASTE DISORDER; TREATMENT INDICATION;

CYSTINOSIS; HUMANS;

EID: 84870410249     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2242-5     Document Type: Review

References (73)

1. Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JH (2009) Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant 24(7):2161-2169
2. Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 1347:111-121
3. Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA (1999) Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66:111-116
4. Gahl WA, Thoene J, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B. (eds) The metabolic and molecular basis of inherited disease, Eighth edition. McGraw-Hill Companies, Inc, pp. 5085-5108
5. Kalatzis V, Antignac C (2002) Cystinosis: from gene to disease. Nephrol Dial Transplant 17:1883-1886
6. Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA (2001) Pulmonary dysfunction in adults with nephropathic cystinosis. Chest 119:394-401
7. Thoene J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT (1999) Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 7:283-289
8. Nesterova G, Gahl WA (2009) Cystinosis, Genereviews website: www.ncbi.nlm.nih.govBookshelf
9. Gahl WA, Thoene JG, Schneider JA, O'Regan S, Kaiser-Kupfer MI, Kuwabara T (1988) NIH conference - Cystinosis: progress in a prototypic disease. Ann Intern Med 109:557-569
10. Pisoni RL, Thoene JG, Christensen HN (1985) Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts: role in therapeutic cystine removal. J Biol Chem 260:4791-4798
11. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD (1982) Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217:1263-1265
12. Park M, Helip-Wooley A, Thoene J (2002) Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 13:2878-2887
13. Thoene JG (2007) A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab 92(4):292-298
14. Sansanwal P, Yen B, Gahl WA, Ma Y, Ying L, Wong LJ, Sarwal MM (2010) Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 21(2):272-283
15. Park M, Thoene J (2005) Potential role of apoptosis in development of the cystinotic phenotype. Pediatr Nephrol 20:441-446
16. Larsen CP, Walker PD, Thoene JG (2010) The incidence of atubular glomeruli in nephropathic cystinosis renal biopsies. Mol Genet Metab 101(4):417-420
17. Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C (2002) Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Bio 22:7622-7632
18. Baum M (1998) The Fanconi syndrome of cystinosis: insights into the pathophysiology. Pediatr Nephrol 12:492-497
19. Roth KS, Foreman JW, Segal S (1981) The Fanconi syndrome and mechanisms of tubular transport dysfunction. Kidney Int 20:705-716
20. Baum M (1993) The cellular basis of Fanconi syndrome. Hosp Pract (Off Ed) 28(11):137-142, Review 147-148
21. Theodoropoulos DS, Shawker TH, Heinrichs C, Gahl WA (1995) Medullary nephrocalcinosis in nephropathic cystinosis. Pediatr Nephrol 9:412-418
22. Winkler L, Offner G, Krull F, Brodehl J (1993) Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152:244-249
23. Bernardini I, Rizzo WB, Dalakas M, Bernar J, Gahl WA (1985) Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75:1124-1130
24. Long WS, Seashore MR, Siegel NJ, Bia MJ (1990) Idiopathic Fanconi syndrome with progressive renal failure: a case report and discussion. Yale J Biol Med 63(1):15-28
25. +-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis. J Am Soc Nephrol 13:2085-2093
26. Manz F, Gretz N (1994) Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Pediatr Nephrol 8:466-471
27. Middleton R, Bradbury M, Webb N, O'Donoghue D, van't Hoff W (2003) Cystinosis. A clinicopathological conference. From toddlers to twenties and beyond Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol Dial Transplant 18:2492-2495
28. Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI (2000) Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71:100-120
29. Gahl WA (1986) Cystinosis coming of age. Adv Pediatr 33:95-126
30. Gahl WA, Hubbard VS, Orloff S (1984) Decreased sweat production in cystinosis. J Pediatr 104:904-905
31. Chik CL, Friedman A, Merriam GR, Gahl WA (1993) Pituitary testicular function in nephropathic cystinosis. Ann Intern Med 119:568-575
32. Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA (2004) Idiopathic intracranial hypertension in cystinosis. J Pediatr 145(5):673-678
33. Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Poisson M (1996) Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 19:65-75
34. Ballantyne AO, Trauner DA (2000) Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis. Neuropsychiatr Neuropsychol Behav Neurol 13:254-263
35. Nesterova G, Gahl W (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23(6):863-867
36. Wühl E, Haffner D, Offner G, Broyer M, van't Hoff W, Mehls O, European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis (2001) Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 138:880-887
37. Schnaper HW, Cottel J, Merrill S, Marcusson E, Kissane JM, Shackelford GD, So SK, Nelson RD, Cole BR, Smith ML, Schneider JA (1992) Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis. J Pediatr 120(4 Pt 1):575-578
38. Mahoney CP, Striker GE (2000) Early development of the renal lesions in infantile cystinosis. Pediatr Nephrol 15:50-56
39. Gahl WA, Balog JZ, Kleta R (2007) Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intl Med 147(4):242-250
40. Almond PS, Matas AJ, Nakhleh RE, Morel P, Troppmann C, Najarian JS, Chavers B (1993) Renal transplantation for infantile cystinosis: long-term follow-up. J Pediatr Surg 28:232-238
41. Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA, NIH Office of Rare Diseases (2005) First NIH/Office of Rare Diseases Conference on cystinosis: past, present, and future. Pediatr Nephrol 20:452-454
42. Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well treated nephropathic cystinosis patients. J Pediatr 145:555-560
43. Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157-1162
44. Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 113:1002-1009
45. Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA (1994) Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35(2):181-188
46. Trauner DA, Fahmy RF, Mishler DA (2001) Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. Pediatr Neurol 24:365-368
47. Zimakas PJ, Sharma AK, Rodd CJ (2003) Osteopenia and fractures in cystinotic children post renal transplantation. Pediatr Nephrol 18:384-390
48. Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Med (Baltimore) 84:137-146
49. O'Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA (2006) Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 4:387-394
50. Treem WR, Rusnack EJ, Ragsdale BD, Seikaly MG, DiPalma JS (1988) Inflammatory bowel disease in a patient with nephropathic cystinosis. Pediatrics 81:584-587
51. Robert JJ, Tête MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M (1999) Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 13(6):524-529
52. Broyer M, Guillot M, Gubler MC, Habib R (1981) Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp 10:137-166
53. Dixit MP, Greifer I (2002) Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up. BMC Nephrol 3:8
54. Ueda M, O'Brien K, Rosing D, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl W (2006) Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 1:555-562
55. Hulton SA, Keffler S, Green A, Taylor CM (1994) Serum cholesterol in children with cystinosis. Abstracts of 32nd Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Edinburgh pg 108
56. Olgar S, Nisli K, Dindar A, Omeroglu RE, Ertugrul T (2006) Can cystinosis cause coronary artery dilatation? Pediatr Cardiol 27:263-268
57. Olcay L, Erdemli E, KesimerM BY, Okur H, Kalkanoolu HS, Coskun T, Altay C (2005) High cystine in platelets from patients with nephropathic cystinosis: a chemical, ultrastructural, and functional evaluation. J Clin Pathol 58:939-945
58. Quinn JP, Royston D, Murphy PT (2004) Bone marrow findings in hereditary cystinosis with renal failure. Am J Hematol 76:79
59. Lucky AW, Howley PM, Megyesi K, Spielberg SP, Schulman JD (1977) Endocrine studies in cystinosis: compensated primary hypothyroidism. J Pediatr 91:204-210
60. Kleta R, Gahl WA (2002) Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 13:2189-2191
61. Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971-977
62. Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA (2005) First NIH/office of rare diseases conference on cystinosis: past, present, and future. Pediatr Nephrol 20(4):452-454
63. Kleta R, Gahl WA (2004) Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother 5:2255-2262
64. Vilaseca MA, Camacho JA, Briones P, Farré C, Mas A (1995) Biochemical follow-up in late-treated nephropathic cystinosis. J Inherit Metab Dis 18:147-150
65. Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease. JAMA 270:2200-2204
66. Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF (1990) Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol 4:129-135
67. Attard M, Jean G, Forestier L, Cherqui S, van't Hoff W, Broyer M, Antignac C, Town M (1999) Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 8:2507-2514
68. Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S (2009) Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114(12):2542-2552
69. Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer H-H, Budde K (2006) Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. J Nephrol 19:677-681
70. Beckman DA, Mullin JJ, Assadi FK (1998) Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development. Teratology 58:96-102
71. Gahl WA (1997) Consultation with the Specialist: nephropathic cystinosis. Pediatr Rev 18:302-304
72. Goodyer P (2011) The history of cystinosis: lessons for clinical management Int. J Nephrol. doi: 10.4061/2011/929456
73. Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P (2012) Servais ACysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 81(2):179-189